Grounds For Filing A Taxotere Lawsuit

Posted by on Oct 22, 2016 in Pharmaceutical Liability | 0 comments

One of the common side effects of chemotherapy is temporary hair loss. After stopping from treatment, patients can expect to see their hair growing back after 3 – 6 months. But one particular drug that has caused much distress to cancer patients is taxotere. Manufactured by Sanofi Aventis and approved by the Food and Drug Administration in 1992, the drug has been associated with permanent alopecia, a side effect that Sanofi concealed to patients.
The website of Williams Kherkher revealed that approximately 10 – 15% of women who used taxotere reported no hair growth for a period of ten years after stopping treatment. Sanofi marketed Taxotere as the more superior chemotherapy drug compared to its competitors. Recently, however, studies showed no indication of the superiority of Taxotere over its competitors.

Sanofi Aventis has recently been the subject of lawsuits filed by cancer patients. A Taxotere alopecia attorney will tell you that Sanofi showed negligence in not informing patients of the serious side effects associated with Taxotere. Some of the grounds for filing a taxotere lawsuit include the following:

  • Failure to warn. Although the Taxotere product information suggested possible hair loss, there was no warning that such hair loss would be lasting in nature.
  • Fraudulent misrepresentation. Lawsuits also alleged that Sanofi misrepresented itself by claiming that rigorous testing has deemed Taxotere as safe and effective for its intended use.
  • Misleading marketing. Plaintiffs also claimed that Sanofi deceived customers by making them believe that hair loss was temporary and that hair would grow back. Likewise, it deceived customers when it marketed taxotere as more superior than its competitor Taxol.
  • Non disclosure of hair loss risks. Despite relevant findings from the GEICAM 9805 study revealing long term hair loss in Taxotere patients and additional reports from female patients, Sanofi allegedly concealed such information to patients and health care providers.

Leave a Reply

Your email address will not be published. Required fields are marked *